Skip to content

Ghana news briefing

U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival

By GhanaSummary Newsroom1 min read
U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival

” Doctors who treat pancreatic cancer hope the drug may usher in more new options for other forms of cancer, with scores of experimental drugs in development.

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.

FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumoUr growth in more than 90% of pancreatic cancer cases.

ShareXFacebookWhatsApp

This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.

Original sources

1 reports

More stories

View all news